Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial [0.03%]
关于复发性胶质母细胞瘤切除范围的评定者一致性差异:前瞻性、随机DIRECTOR试验的事后分析补充研究
Philipp Karschnia,Nico Teske,Emilie Le Rhun et al.
Philipp Karschnia et al.
Background: Tumor resection is a prerequisite in many studies of new glioblastoma therapeutics; however, no clear parameters for "resectability" exist. We evaluated inter-rater variability in assessing tumor resectability...
Automatic Extraction of PET RANO Criteria with an Externally Validated Deep Learning Model: Application to [18F]FDOPA PET Imaging [0.03%]
基于外部验证的深度学习模型自动提取PET-RANO标准及其在[18F]FDOPA-PET成像中的应用
Timothée Zaragori,Laura Rozenblum,Guido Rovera et al.
Timothée Zaragori et al.
Background: Automatic segmentation of gliomas on amino acid PET is essential for quantitative tumor assessment, a pillar in monitoring gliomas under treatment. This study aimed to develop a deep learning model for the aut...
Molecular modulators of CDK4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening [0.03%]
通过全基因组CRISPR-Cas9筛选鉴定出的实验性胶质瘤中针对CDK4/6抑制剂反应的分子调节因子
Surender Surender,Lara Annina Haeusser,Laurence Kuhlburger et al.
Surender Surender et al.
Background: Glioblastoma harbors frequent alterations in the retinoblastoma (RB1) pathway, providing a genetic rationale for therapeutic targeting with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors. The NOA-20 trial did...
Phase separation of TRNAU1AP protein sustains selenoprotein translation and promotes glioblastoma tumorigenesis [0.03%]
TRNAU1AP蛋白的相分离利于硒蛋白合成并促进胶质母细胞瘤发生发展
Xiaowei Zhang,Li Li,Linlin Li et al.
Xiaowei Zhang et al.
Background: Glioblastoma (GBM) depends on selenoproteins, yet the mechanisms underlying their dysregulation remain poorly understood. The tRNA-binding protein TRNAU1AP also remains largely uncharacterized, with its mechan...
A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in IDH-mutant astrocytoma patients [0.03%]
全面的临床、分子、影像学和手术分析可预测IDH突变型胶质瘤患者的预后
Minjee Cho,Minjin Kim,Hyeonjin Kim et al.
Minjee Cho et al.
Background: To comprehensively investigate clinical, molecular, radiological, and surgical factors for prediction of progression-free survival (PFS) in patients with isocitrate dehydrogenase (IDH)-mutant astrocytomas. ...
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy [0.03%]
放射性药物治疗较外部束放射治疗对脑膜转移癌的生存优势更佳
Lei Zhao,Paul A Clark,Jack M Shireman et al.
Lei Zhao et al.
Background: Leptomeningeal metastasis from a solid tumor carries a dismal prognosis with median survival of 3 to 5 months after diagnosis and treatment with external beam radiation therapy. It targets the whole-brain or t...
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma [0.03%]
ZFTA-RELA 基因融合室管膜瘤的治疗新靶点——核输出路径
Siri M Ippagunta,Amir Arabzade,Srinidhi Varadharajan et al.
Siri M Ippagunta et al.
Background: Ependymoma (EPN) is the third most common pediatric brain tumor with no targeted therapies available to patients. In supratentorial ependymoma, the most frequent driver alteration is a gene fusion between ZFTA...
5-ALA-mediated PpIX Accumulation in the Tumor Microenvironment of Glioma and its Implications for 5-ALA-based Local Tumor Therapies: A Review of the Literature [0.03%]
5-氨基乙酰丙酸介导的胶质瘤肿瘤微环境中原卟啉 IX 蓄积及其对基于 5-氨基乙酰丙酸局部肿瘤治疗的意义:文献综述
Zeynep Özdemir,Marco Gallus,Michael Müther et al.
Zeynep Özdemir et al.
5-Aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) accumulation is widely used for fluorescence-guided surgery in malignant glioma. Beyond its diagnostic role, PpIX exhibits photo-, sono-, and radiosensitizing properties that en...
Expanding the scope of collective responsibility in neuro-oncology: the integrity of the published record [0.03%]
神经肿瘤学中集体责任范围的扩大:发表记录的完整性
Timothy Daly,Jaime A Teixeira Da Silva
Timothy Daly